Cargando…
Adoptive T‐cell therapy targeting Epstein–Barr virus as a treatment for multiple sclerosis
Emergence of a definitive link between Epstein–Barr virus (EBV) and multiple sclerosis has provided an impetus to develop immune‐based therapies to target EBV‐infected B cells. Initial studies with autologous EBV‐specific T‐cell therapy demonstrated that this therapy is safe with minimal side effect...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028422/ https://www.ncbi.nlm.nih.gov/pubmed/36960148 http://dx.doi.org/10.1002/cti2.1444 |